a nonsignificant trendP =.087
There was a nonsignificant trend toward higher angiotensin pathway-modifying drug use in the HHE group (70% vs 56%; P =.087), but detailed dose data were not collected.
There was a nonsignificant trend toward higher angiotensin pathway-modifying drug use in the HHE group (70% vs 56%; P =.087), but detailed dose data were not collected.